Karen Flynn Sells Shares of Stevanato Group

Karen Flynn, an insider at Stevanato Group S.p.A. (NYSE:STVN), sold 1,493 shares on June 15, 2026. The shares were sold at an average price of $17.09 each, bringing the total transaction value to approximately $25,515.

Insider Buying and Selling at Stevanato Group S.p.A.

In addition to Karen Flynn's sale, several other insiders made transactions around the same time. On June 15, 2026, William Federici, Madhavan Balachandran, and Donald Morel Jr. each sold 1,493 shares at the same price of $17.09. Earlier, on June 12, 2026, William Federici purchased 4,975 shares, and Marco Dal Lago, the Chief Financial Officer, bought 2,356 shares, both at no cost.

Other Institutional Activity in Stevanato Group

Institutional investors have also been active in Stevanato Group. Conestoga Capital Advisors, LLC increased its holdings by 602,050 shares, ending with 8,491,751 shares valued at approximately $116.76 million, a 7.6% increase. Neuberger Berman Group LLC, however, reduced its position by 312,219 shares, bringing its total to 4,475,492 shares worth about $61.54 million, a 6.5% decrease. Similarly, TimesSquare Capital Management, LLC trimmed its holdings by 10,605 shares, now holding 3,489,716 shares valued at $47.98 million. T. Rowe Price Investment Management, Inc. decreased its stake by 698,724 shares, totaling 3,224,908 shares worth $44.34 million, a 17.8% drop. Meanwhile, Bamco Inc /NY/ boosted its position by 498,714 shares to 2,500,438 shares, valued at $34.38 million, a 24.9% increase.

Stevanato Group S.p.A. Stock Down 12.6%

Shares of Stevanato Group traded near $18.39 on Friday. The company, with a market cap of approximately $5.02 billion, has a P/E ratio of 31.71 and a forward P/E of 21.95. Its beta is 0.776, indicating lower volatility compared to the market. The stock's 52-week range is between $12.89 and $28.00, with a 50-day moving average of $17.39 and a 200-day moving average of $19.57. The company's current ratio stands at 1.632, and it has a debt-to-equity ratio of 29.434.

Recent Earnings

In its most recent financial results, Stevanato Group reported revenue of $1.20 billion, reflecting a growth of 6.6%. The company achieved a net margin of 11.75% and a return on equity of 9.59%. Its earnings per share (EPS) were $0.58. The next earnings report is scheduled for May 7, 2026.

Dividend

Stevanato Group offers an annual dividend rate of $0.06, yielding 0.34%. The dividend payout ratio is 10.59%.

Analysts Set New Price Targets

On June 16, 2026, TD Cowen initiated coverage on Stevanato Group with a 'buy' rating and set a price target of $25. Earlier, on June 2, 2026, Wolfe Research assumed coverage with a 'buy' rating and a $21 target. The consensus among analysts is a 'buy' rating, with a mean target price of $24.45 based on 10 opinions.

About Stevanato Group

Stevanato Group S.p.A., headquartered in Piombino Dese, Italy, is a leader in the healthcare sector, specifically in medical instruments and supplies. Founded in 1949, the company designs, produces, and distributes a range of products and services for the biopharma and healthcare industries across Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. With over 6,010 employees, the company is led by CEO Franco Stevanato.

Bottom Line

Karen Flynn's recent share sale at Stevanato Group adds to the flurry of insider activity in June. Investors often track these transactions for insights into company sentiment. It's important to remember that such insider trades are reported after the fact and may not reflect current holdings or intentions.